Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)

NCT00651456 is registered in ClinicalTrials.gov with Intergroupe Francophone de Cancerologie Thoracique as lead sponsor.

NCT NCT00651456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00651456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II-III Randomized Trial Pemetrexed-Cisplatin Chemotherapy With or Without Bevacizumab (Avastin), 15 mg/kg, for Malignant Pleural Mesothelioma (MPM)
Lead sponsor
Intergroupe Francophone de Cancerologie Thoracique
Phase
Phase 2/3
Overall status
Completed
Start date
February 29, 2008
Completion date
September 30, 2016
Enrollment
448 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma